The search for potent and brain penetrant inhibitors of NLRP3 has become an area of drug discovery focus in recent years with biological validation relying heavily on data generated in various rodent models of neurodegenerative disease with a reference compound MCC950. Here, NLRP3 is linked to neurodegenerative disease.